Bibliographic citations
This is an automatically generated citacion. Modify it if you see fit
Rojas, N., (2021). Diabetes mellitus tipo 2 como factor de riesgo para tuberculosis multidrogorresistente en Perú [Tesis, Universidad Privada Antenor Orrego]. https://hdl.handle.net/20.500.12759/7814
Rojas, N., Diabetes mellitus tipo 2 como factor de riesgo para tuberculosis multidrogorresistente en Perú [Tesis]. PE: Universidad Privada Antenor Orrego; 2021. https://hdl.handle.net/20.500.12759/7814
@misc{renati/380659,
title = "Diabetes mellitus tipo 2 como factor de riesgo para tuberculosis multidrogorresistente en Perú",
author = "Rojas Paredes, Noemí Natalí",
publisher = "Universidad Privada Antenor Orrego",
year = "2021"
}
Title: Diabetes mellitus tipo 2 como factor de riesgo para tuberculosis multidrogorresistente en Perú
Authors(s): Rojas Paredes, Noemí Natalí
Advisor(s): Segura Plasencia, Niler Manuel
OCDE field: http://purl.org/pe-repo/ocde/ford#3.02.27
Issue Date: 2021
Institution: Universidad Privada Antenor Orrego
Abstract: Identificar si la Diabetes Mellitus tipo 2 es un factor de riesgo para
Tuberculosis Multidrogorresistente (TBMDR) en Perú.
MATERIAL Y MÉTODO: muestra censal de pacientes con TBMDR y con diseño
de estudio observacional, analítico, retrospectivo tipo casos y controles, registrados
en la base de datos de todos los Establecimientos de ESSALUD – Perú, entre enero
2013 a diciembre del 2017.
RESULTADOS: No se halló relación estadísticamente significativa entre la DM2
y TBMDR (OR= 1,0; IC95% 0,8 – 1,3; p= 0,85). La mediana de la edad fue de 33
años para los casos [RIC 25 - 50] y de 42 años para los controles [RIC 27 - 62]. En
el análisis multivariado se encontró a la edad como factor protector para TBMDR
(OR= 0,9; IC95% 0,97 – 0,98; p= 0,00), y como factores de riesgo: contacto con
paciente TBMDR (OR= 17,2; IC95% 10,6 – 27,9; p= 0,00), tratamiento
antituberculoso irregular (OR= 8,6; IC95% 7,0 – 10,5; p= 0,00) y zona de vivienda
urbana (OR= 2,3; IC95% 1,4 – 3,9; p= 0,00).
CONCLUSIÓN: La Diabetes Mellitus tipo 2 no es un factor de riesgo para
Tuberculosis Multidrogorresistente en Perú.
Identify whether Type 2 Diabetes Mellitus (T2DM) is a risk factor for Multidrug-resistant Tuberculosis (MDR-TB) in Peru. MATERIAL AND METHOD: Study samples were applicants diagnosed with MDR TB. Method applied was an observational, analytical, and retrospective type review of cases and vitals. All cases were registered in the Peruvian Ministry of Health’s Office of Public Health (ESSALUD) database between January 2013 through December 2017. RESULTS: There was no significant statistical correlation found between T2DM and MDR-TB (OR= 1.0; 95% CI 0.8 to 1.3; p = 0.85) The median age was 33 years [RIC 25 - 50] and 42 years [RIC 27 - 62]. The multivariate analysis found age as a protective factor for MDR-TB (OR= 0.9; 95% CI 0.97 to 0.98; p= 0.00) and as risk factors: contact with a patient diagnosed with MDR-TB (OR= 17.2; 95% CI 10.6 to 27.9; p= 0.00), irregular anti-tuberculosis treatment (OR= 8.6; 95% CI 7.0 to 10.5; p= 0.00), and those residing in urban areas (OR= 2.3; 95% CI 1.4 to 3.9; p= 0.00). CONCLUSION: Type 2 Diabetes Mellitus is not a risk factor for a patient diagnosed with Multidrug-resistant Tuberculosis in Peru.
Identify whether Type 2 Diabetes Mellitus (T2DM) is a risk factor for Multidrug-resistant Tuberculosis (MDR-TB) in Peru. MATERIAL AND METHOD: Study samples were applicants diagnosed with MDR TB. Method applied was an observational, analytical, and retrospective type review of cases and vitals. All cases were registered in the Peruvian Ministry of Health’s Office of Public Health (ESSALUD) database between January 2013 through December 2017. RESULTS: There was no significant statistical correlation found between T2DM and MDR-TB (OR= 1.0; 95% CI 0.8 to 1.3; p = 0.85) The median age was 33 years [RIC 25 - 50] and 42 years [RIC 27 - 62]. The multivariate analysis found age as a protective factor for MDR-TB (OR= 0.9; 95% CI 0.97 to 0.98; p= 0.00) and as risk factors: contact with a patient diagnosed with MDR-TB (OR= 17.2; 95% CI 10.6 to 27.9; p= 0.00), irregular anti-tuberculosis treatment (OR= 8.6; 95% CI 7.0 to 10.5; p= 0.00), and those residing in urban areas (OR= 2.3; 95% CI 1.4 to 3.9; p= 0.00). CONCLUSION: Type 2 Diabetes Mellitus is not a risk factor for a patient diagnosed with Multidrug-resistant Tuberculosis in Peru.
Link to repository: https://hdl.handle.net/20.500.12759/7814
Discipline: Medicina
Grade or title grantor: Universidad Privada Antenor Orrego. Facultad de Medicina Humana
Grade or title: Médico Cirujano
Juror: Mejía Sánchez, Gilmar Robert; López Deza, María Ysabel; Chávez Rimarachín, Manuel Berton
Register date: 29-Jul-2021
This item is licensed under a Creative Commons License